Computational Insights into Kinetic Hindrance Affecting Crystallization of Stable Forms of Active Pharmaceutical Ingredients
- 30 January 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 20 (3) , 1512-1525
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Why don't we find more polymorphs?Acta crystallographica Section B, Structural science, crystal engineering and materials, 2013
- Evaluation of molecular crystal structures using Full Interaction MapsCrystEngComm, 2012
- Thermodynamic and structural study of tolfenamic acid polymorphsJournal of Pharmaceutical and Biomedical Analysis, 2009
- Intermolecular contacts influencing the conformational and geometric features of the pharmaceutically preferred mebendazole polymorph CJournal of Pharmaceutical Sciences, 2009
- Significant progress in predicting the crystal structures of small organic molecules – a report on the fourth blind testActa crystallographica Section B, Structural science, crystal engineering and materials, 2009
- Crystallisation within transdermal rotigotine patch: is there cause for concern?Expert Opinion on Drug Delivery, 2008
- Agglomeration and adhesion free energy of paracetamol crystals in organic solventsAIChE Journal, 2007
- Nucleation of crystals from their liquid phaseComptes Rendus. Physique, 2006
- Identifying the Stable Polymorph Early in the Drug Discovery–Development ProcessPharmaceutical Development and Technology, 2005
- From molecules to solids with the DMol3 approachThe Journal of Chemical Physics, 2000